Education and Training:

B.S., University of Kansas, Lawrence, KS (1978)

M.D., University of Kansas, Kansas City, KS (1982)

Internship/Residency, Department of Medicine, Rhode Island Hospital, Providence, RI (1982-85)

Fellowship, Department of Medicine, Division of Hematology, University of Washington, Seattle, WA (1986-89)

Michael L. Linenberger, M.D., F.A.C.P.
Professor of Medicine
Division of Hematology
Associate Program Director, Hematology/Oncology Fellowship
University of Washington School of Medicine

Medical Director, Apheresis and Cellular Therapy,
Seattle Cancer Care Alliance
Associate Member,
Fred Hutchinson Cancer Research Center

CURRENT CLINICAL INTERESTS

Hematologic malignancies, benign hematologic disorders, bleeding and thrombotic disorders, therapeutic apheresis and stem cell procurement

CURRENT RESEARCH INTERESTS

Extracorporeal photochemotherapy for pediatric graft-versus-host disease and safety of peripheral blood stem cell mobilization and collection in elderly donors

SELECTED PUBLICATIONS

Linenberger ML and Price TH:  Use of cellular and plasma apheresis in the critically ill patient. Part I: Technical and physiological considerations. J. Intensive Care Medicine 20:18-27, 2005.

Linenberger ML:  CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of resistance. Leukemia 19:176-182, 2005.

Linenberger ML and Price TH:  Use of cellular and plasma apheresis in the critically ill patient. Part II: Clinical indications and applications. J. Intensive Care Medicine 20:88-103, 2005.

Linenberger ML and Wittkowski, A.K. Thromboembolic complications of malignancy: Part 1. Risks. Oncology 19:853-861, 2005.

Linenberger ML and Wittkowski, A.K. Thromboembolic complications of malignancy: Part 2. Management. Oncology 19:1077-1084, 2005.

Linenberger M:  Catheter-related thrombosis: risks, diagnosis and management.  J. Natl. Canc Netw 4:889-901, 2006.

Nester T, and Linemberger M:  Therapeutic apheresis: technical considerations and medications in critical care.  In: Intensive Care Medicine, 6th ed., Richard S. Irwin and James M. Rippe (eds), Lippincott Williams & Wilkins, 2008.